Limits...
A Suitable Approach to Estimate Cancer Incidence in Area without Cancer Registry.

Mitton N, Colonna M, Trombert B, Olive F, Gomez F, Iwaz J, Polazzi S, Schott-Petelaz AM, Uhry Z, Bossard N, Remontet L - J Cancer Epidemiol (2011)

Bottom Line: Results.Conclusion.Incidence estimation using PMSI patient identifiers proved encouraging though still dependent on the assumption of uniform cancer treatments and coding.

View Article: PubMed Central - PubMed

Affiliation: Registre des Cancers de l'Isère, 38240 Meylan, France.

ABSTRACT
Objective. Use of cancer cases from registries and PMSI claims database to estimate Département-specific incidence of four major cancers. Methods. Case extraction used principal diagnosis then surgery codes. PMSI cases/registry cases ratios for 2004 were modelled then Département-specific incidence for 2007 estimated using these ratios and 2007 PMSI cases. Results. For 2007, only colon-rectum and breast cancer estimations were satisfactorily validated for infranational incidence not ovary and kidney cancers. For breast, the estimated national incidence was 50,578 cases and the incidence rate 98.6 cases per 100,000 person per year. For colon-rectum, incidence was 21,172 in men versus 18,327 in women and the incidence rate 38 per 100,000 versus 24.8. For ovary, the estimated incidence was 4,637 and the rate 8.6 per 100,000. For kidney, incidence was 6,775 in men versus 3,273 in women and the rate 13.3 per 100.000 versus 5.2. Conclusion. Incidence estimation using PMSI patient identifiers proved encouraging though still dependent on the assumption of uniform cancer treatments and coding.

No MeSH data available.


Related in: MedlinePlus

Map of SIR of colon-rectum cancer in women.
© Copyright Policy - open-access
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3065037&req=5

fig3: Map of SIR of colon-rectum cancer in women.

Mentions: Département-specific estimations for colon-rectum and breast cancer are shown in Table 4 and SIR maps of these cancers are shown in Figures 2, 3, 4. These maps were not constructed for ovary and kidney cancers because of difficult formal validations of Département-specific incidence.


A Suitable Approach to Estimate Cancer Incidence in Area without Cancer Registry.

Mitton N, Colonna M, Trombert B, Olive F, Gomez F, Iwaz J, Polazzi S, Schott-Petelaz AM, Uhry Z, Bossard N, Remontet L - J Cancer Epidemiol (2011)

Map of SIR of colon-rectum cancer in women.
© Copyright Policy - open-access
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3065037&req=5

fig3: Map of SIR of colon-rectum cancer in women.
Mentions: Département-specific estimations for colon-rectum and breast cancer are shown in Table 4 and SIR maps of these cancers are shown in Figures 2, 3, 4. These maps were not constructed for ovary and kidney cancers because of difficult formal validations of Département-specific incidence.

Bottom Line: Results.Conclusion.Incidence estimation using PMSI patient identifiers proved encouraging though still dependent on the assumption of uniform cancer treatments and coding.

View Article: PubMed Central - PubMed

Affiliation: Registre des Cancers de l'Isère, 38240 Meylan, France.

ABSTRACT
Objective. Use of cancer cases from registries and PMSI claims database to estimate Département-specific incidence of four major cancers. Methods. Case extraction used principal diagnosis then surgery codes. PMSI cases/registry cases ratios for 2004 were modelled then Département-specific incidence for 2007 estimated using these ratios and 2007 PMSI cases. Results. For 2007, only colon-rectum and breast cancer estimations were satisfactorily validated for infranational incidence not ovary and kidney cancers. For breast, the estimated national incidence was 50,578 cases and the incidence rate 98.6 cases per 100,000 person per year. For colon-rectum, incidence was 21,172 in men versus 18,327 in women and the incidence rate 38 per 100,000 versus 24.8. For ovary, the estimated incidence was 4,637 and the rate 8.6 per 100,000. For kidney, incidence was 6,775 in men versus 3,273 in women and the rate 13.3 per 100.000 versus 5.2. Conclusion. Incidence estimation using PMSI patient identifiers proved encouraging though still dependent on the assumption of uniform cancer treatments and coding.

No MeSH data available.


Related in: MedlinePlus